The PharmaSea project is working to make viable drug candidates of novel compounds found under the sea. LSIPR discovers how the EU-funded initiative does it.
We’re running out of new drugs. Since the 1980s, the number of new antibiotics being discovered and making it through the pipeline has been steadily dropping. Meanwhile, disease-causing microbes are becoming resistant to our old drugs.
The World Health Organization fears a “post-antibiotic era”, where common infections and minor injuries can kill. “Far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century,” the organisation said in its April report on microbial resistance.
While there are efforts to tackle this problem from economic and educational angles, some researchers are turning to the world’s oceans in the search for new drug candidates.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
PharmaSea; WHO; antibiotics; generic drugs; antibiotics.